for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Inogen Inc

INGN.OQ

Latest Trade

48.62USD

Change

-0.47(-0.96%)

Volume

325,652

Today's Range

47.76

 - 

50.01

52 Week Range

41.23

 - 

259.99

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
49.09
Open
48.95
Volume
325,652
3M AVG Volume
12.71
Today's High
50.01
Today's Low
47.76
52 Week High
259.99
52 Week Low
41.23
Shares Out (MIL)
21.93
Market Cap (MIL)
1,066.42
Forward P/E
44.86
Dividend (Yield %)
--

Latest Developments

More

Inogen Reports Q2 Earnings Per Share $0.45

Inogen Announces Q1 Earnings Per Share Of $0.24

Inogen Announces Fourth Quarter Results And Updates 2019 Guidance

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Inogen Inc

Inogen, Inc. is a medical technology company. The Company develops, manufactures and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The Company's Inogen One systems concentrate the air around the patient to offer a single source of supplemental oxygen anytime, anywhere with a portable device. Its three portable product offerings, the Inogen One G4, Inogen One G3 and Inogen One G2, at approximately 2.8, 4.8 and 7.0 pounds with a single battery, respectively. Its Inogen One G4, Inogen One G3 and Inogen One G2 are sub-3, sub-5 and sub-10 pound portable oxygen concentrators, respectively. All of its Inogen One systems are equipped with Intelligent Delivery Technology. The Inogen At Home stationary oxygen concentrator allows it to access the non-ambulatory oxygen patient market and serves as a backup to its Inogen One system for ambulatory patients on its rental service.

Industry

Medical Equipment & Supplies

Contact Info

326 Bollay Dr

+1.805.5620500

https://www.inogen.com/

Executive Leadership

Heath Lukatch

Independent Chairman of the Board

Scott Wilkinson

President, Chief Executive Officer, Director

Alison Bauerlein

Executive Vice President - Finance and Chief Financial Officer, Corporate Secretary and Corporate Treasurer

Byron Myers

Executive Vice President of Sales and Marketing

Bart Sanford

Executive Vice President, Operations

Key Stats

2.71 mean rating - 7 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

0.2K

2017

0.2K

2018

0.4K

2019(E)

0.4K
EPS (USD)

2016

0.970

2017

1.310

2018

2.300

2019(E)

1.084
Price To Earnings (TTM)
26.06
Price To Sales (TTM)
2.86
Price To Book (MRQ)
3.19
Price To Cash Flow (TTM)
20.13
Total Debt To Equity (MRQ)
0.00
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
13.05
Return on Equity (TTM)
11.39

Latest News

Short seller Carson Block targets medical device company Inogen

Prominent short seller Carson Block is saying that medical device company Inogen Inc has inflated the size of its markets and expects the stock price to fall.

Short seller Carson Block targets medical device company Inogen

Prominent short seller Carson Block is saying that medical device company Inogen Inc has inflated the size of its markets and expects the stock price to fall.

Inogen's shares drop on short seller Citron's tweet

Shares of Inogen Inc fell nearly 7 percent on Thursday after short seller Citron Research called the oxygen supply device maker the most expensive name in medical technology with no pipeline.

BRIEF-Inogen Q1 Earnings Per Share $0.48

* INOGEN ANNOUNCES RECORD FIRST QUARTER 2018 FINANCIAL RESULTS AND INCREASES 2018 GUIDANCE

Oxygen device maker Inogen discloses customer data breach

Oxygen supply device maker Inogen Inc said on Friday it was notifying 30,000 existing and former customers following a data breach that led to improper access of personal details of some rental clients.

BRIEF-Inogen Discloses Data Breach

* INOGEN INC - ON APRIL 13, 2018, COMPANY ANNOUNCED THAT IT EXPERIENCED A DATA SECURITY INCIDENT

Inogen discloses data breach

Medical technology company Inogen Inc on Friday disclosed that one of its employee's email accounts was breached and personal information belonging to its rental customers was accessed as well as its own non-public financial information.

BRIEF-Inogen Sees FY 2018 Revenue $298 Million To $308 Million

* INOGEN ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND UPDATES 2018 GUIDANCE

BRIEF-Inogen Sees FY 2018 revenue $295 million to $305 million

* Inogen announces record third quarter 2017 financial results

BRIEF-Inogen qtrly earnings per share $0.38

* Inogen announces record second quarter 2017 financial results

BRIEF-Inogen secures additional facility to support direct-to-consumer sales growth

* Inogen secures additional facility to support direct-to-consumer sales growth

BRIEF-Inogen provides impact from 21st Century Cures Act

* Inogen Inc - announced estimated impact of 21(st)century cures act to its 2016 financial results

BRIEF-Inogen announces third quarter 2016 financial results

* Sees FY 2017 revenue up 17.3 to 20.4 percent Source text for Eikon: Further company coverage:

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up